Tag: Cellectar Biosciences

Cellectar Biosciences finds itself at a pivotal moment, with a convergence of regulatory progress, financial maneuvers, and pipeline expansion creating ...

Cellectar Biosciences shares are experiencing significant downward pressure in the wake of a recently completed financing arrangement. Despite successfully securing ...

Cellectar Biosciences has achieved a critical regulatory milestone that could pave the way for European commercialization of its cancer therapeutic ...

Cellectar Biosciences is attracting significant market attention following the release of encouraging interim data from its CLOVER-2 Phase 1b study. ...